https://www.selleckchem.com/pr....oducts/gpr84-antagon
424 (95% confidence interval 0.187-0.962; = 0.04, upon discharge than patients using other anti-hypertensive drugs. A sub-group analysis showed that the effect of discontinuing use of ACEIs/ARBs was stronger in moderate cases [hazard ratio = 0.224 (95% confidence interval 0.005-0.998; = 0.0497)]. Patients in the discontinued ACEIs/ARBs group had longer hospital stays. Our findings suggest that COVID-19 patients complicated with hypertension should continue to use ACEIs/ARBs. Patients in the discontinued ACEIs/ARBs group had
Like
Comment
Share
